对 "抑郁症和肥胖症患者使用塞马鲁肽的安全性 "的回应。

{"title":"对 \"抑郁症和肥胖症患者使用塞马鲁肽的安全性 \"的回应。","authors":"Robert F. Kushner, Thomas A. Wadden","doi":"10.1002/oby.24144","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":215,"journal":{"name":"Obesity","volume":"32 12","pages":"2218"},"PeriodicalIF":4.2000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Response to “The safety of semaglutide in patients with depression and obesity”\",\"authors\":\"Robert F. Kushner, Thomas A. Wadden\",\"doi\":\"10.1002/oby.24144\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":215,\"journal\":{\"name\":\"Obesity\",\"volume\":\"32 12\",\"pages\":\"2218\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/oby.24144\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/oby.24144","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}